These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 27600840

  • 21. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y, Zhang J, Zhu Y, Zhang J, Shen H, Lu J, Pan X, Lin N, Dai X, Zhou M, Chen X.
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH, Baek SJ, Heo S, Park HJ, Kwon H, Lee S, Jung J, Park SJ, Kim BC, Lee YC, Ryu JH, Kim DH.
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Chen X, Hu J, Jiang L, Xu S, Zheng B, Wang C, Zhang J, Wei X, Chang L, Wang Q.
    Neuroscience; 2014 Oct 24; 279():94-101. PubMed ID: 25193238
    [Abstract] [Full Text] [Related]

  • 28. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model.
    Shen Y, Tian M, Zheng Y, Gong F, Fu AKY, Ip NY.
    Cell Rep; 2016 Nov 08; 17(7):1819-1831. PubMed ID: 27829153
    [Abstract] [Full Text] [Related]

  • 29. Risperidone ameliorated Aβ1-42-induced cognitive and hippocampal synaptic impairments in mice.
    Wu L, Feng X, Li T, Sun B, Khan MZ, He L.
    Behav Brain Res; 2017 Mar 30; 322(Pt A):145-156. PubMed ID: 28093254
    [Abstract] [Full Text] [Related]

  • 30. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD, Bailey LA, Cozart MA, Gannon BM, Gottschall PE.
    Acta Neuropathol Commun; 2015 Sep 04; 3():54. PubMed ID: 26337292
    [Abstract] [Full Text] [Related]

  • 31. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
    Deibel SH, Weishaupt N, Regis AM, Hong NS, Keeley RJ, Balog RJ, Bye CM, Himmler SM, Whitehead SN, McDonald RJ.
    Brain Res; 2016 Sep 01; 1646():12-24. PubMed ID: 27208489
    [Abstract] [Full Text] [Related]

  • 32. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ, Klyubin I, Wang Q, Anwyl R.
    Biochem Soc Trans; 2005 Aug 01; 33(Pt 4):563-7. PubMed ID: 16042545
    [Abstract] [Full Text] [Related]

  • 33. β-Amyloid triggers aberrant over-scaling of homeostatic synaptic plasticity.
    Gilbert J, Shu S, Yang X, Lu Y, Zhu LQ, Man HY.
    Acta Neuropathol Commun; 2016 Dec 13; 4(1):131. PubMed ID: 27955702
    [Abstract] [Full Text] [Related]

  • 34. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
    Zhang H, Zhang L, Zhou D, He X, Wang D, Pan H, Zhang X, Mei Y, Qian Q, Zheng T, Jones FE, Sun B.
    Neurobiol Dis; 2017 Oct 13; 106():171-180. PubMed ID: 28684271
    [Abstract] [Full Text] [Related]

  • 35. Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    Watremez W, Jackson J, Almari B, McLean SL, Grayson B, Neill JC, Fischer N, Allouche A, Koziel V, Pillot T, Harte MK.
    J Alzheimers Dis; 2018 Oct 13; 62(1):213-226. PubMed ID: 29439327
    [Abstract] [Full Text] [Related]

  • 36. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
    Luo J, Lee SH, VandeVrede L, Qin Z, Ben Aissa M, Larson J, Teich AF, Arancio O, D'Souza Y, Elharram A, Koster K, Tai LM, LaDu MJ, Bennett BM, Thatcher GR.
    Mol Neurodegener; 2016 Apr 29; 11():35. PubMed ID: 27129593
    [Abstract] [Full Text] [Related]

  • 37. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK, Kim HG, Baek SH, Jung WR, Park DI, Park JS, Jo DG, Kim KL.
    Neurobiol Aging; 2014 May 29; 35(5):990-1001. PubMed ID: 24268884
    [Abstract] [Full Text] [Related]

  • 38. Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.
    Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC, Hyman BT, Shatz CJ.
    Science; 2013 Sep 20; 341(6152):1399-404. PubMed ID: 24052308
    [Abstract] [Full Text] [Related]

  • 39. Ketones block amyloid entry and improve cognition in an Alzheimer's model.
    Yin JX, Maalouf M, Han P, Zhao M, Gao M, Dharshaun T, Ryan C, Whitelegge J, Wu J, Eisenberg D, Reiman EM, Schweizer FE, Shi J.
    Neurobiol Aging; 2016 Mar 20; 39():25-37. PubMed ID: 26923399
    [Abstract] [Full Text] [Related]

  • 40. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
    Zhang JH, Yu LJ, Yang H, Hui Z, Jiang S, Chen L, Zhao Y, Wang SL, Liu Y, Xu Y.
    BMC Complement Altern Med; 2018 May 29; 18(1):167. PubMed ID: 29843688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.